-
-
LEVOPHED (Brand for NOREPINEPHRINE BITARTRATE)
- QTY 4
- 1 MG/ML
- VIAL
- Near 77381
NOREPINEPHRINE (nor ep ih NEFF rin) is a very strong vasoconstrictor. This medicine is used in a hospital to treat low blood pressure.
Change Location
Set Price Drop Alert for:
LEVOPHED (Brand for NOREPINEPHRINE BITARTRATE)
- QTY 4
- 1 MG/ML
- VIAL
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
LEVOPHED (Brand for NOREPINEPHRINE BITARTRATE)
- QTY 4
- 1 MG/ML
- VIAL
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Generic Available
Medicine Chest
LEVOPHED (Brand for NOREPINEPHRINE BITARTRATE) Lifestyle Interactions
-
Norepinephrine Bitartrate 1mg/1mL, Solution for injection
• Interaction: Caffeine-containing Foods/Beverages• Severity: Moderate• Notes for Consumers: Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Norepinephrine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Norepinephrine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.• Notes for Professionals: Caffeine is a CNS-stimulant and such actions are expected to be additive when coadministered with other CNS stimulants or psychostimulants.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
